Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proliferative radiation retinopathy

J L Kinyoun1, B S Lawrence, W E Barlow

  • 1Department of Ophthalmology, University of Washington, Seattle, USA.

Archives of Ophthalmology (Chicago, Ill. : 1960)
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust": [Annals of Oncology 32 (2021) 1077-1082].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.

Breast cancer research and treatment·2016
Same author

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.

The pharmacogenomics journal·2013
Same author

Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.

Journal of the National Cancer Institute·2010
Same journal

The economics of the initial preventive physical examination in medicare-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Modification of silicone oil retention sutures in aphakic eyes with iris loss-reply;.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

December 2011 archives web quiz winner.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

About this journal.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

In memoriam: goodwin m. Breinin, MD (1918-2011).

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
See all related articles

Proliferative radiation retinopathy (PRR) significantly impacts vision more than nonproliferative radiation retinopathy (NPRR). Panretinal photocoagulation effectively reduces new vessel growth in PRR, though vision retention remains poor.

Area of Science:

  • Ophthalmology
  • Radiation Oncology
  • Retinal Diseases

Background:

  • Radiation retinopathy is a known complication of radiotherapy involving the eye.
  • Proliferative radiation retinopathy (PRR) represents a more advanced stage than nonproliferative radiation retinopathy (NPRR).
  • Understanding the differences and treatment outcomes is crucial for patient management.

Purpose of the Study:

  • To compare the clinical characteristics and visual outcomes of proliferative radiation retinopathy (PRR) and nonproliferative radiation retinopathy (NPRR).
  • To evaluate the effectiveness of panretinal photocoagulation (PRP) treatment for PRR.

Main Methods:

  • Retrospective review of medical records, fundus photographs, and fluorescein angiograms.
  • Inclusion of 10 patients (14 eyes) with PRR and 17 patients (27 eyes) with NPRR over a 20-year period.

Related Experiment Videos

  • Data analysis included radiotherapy details, visual acuity, and response to PRP treatment.

    • Main Results:

    • Eyes with PRR had significantly worse median visual acuity (20/400) compared to NPRR (20/50) at follow-up.
    • A higher proportion of PRR eyes (86%) had visual acuity of 20/200 or worse than NPRR eyes (26%).
    • Panretinal photocoagulation led to resolution of new vessels in 91% of treated PRR eyes.

    Conclusions:

    • PRR is associated with a poor prognosis for maintaining or regaining central vision.
    • Panretinal photocoagulation demonstrates long-term efficacy in controlling neovascularization in PRR.
    • Early detection and intervention are vital for managing radiation retinopathy complications.